Redeye is encouraged by the results from the LION study, demonstrating penetration of laquinimod int...
Nettoomsättningen för det första kvartalet 2025 uppgick till 122,7 MSEK (106,0), motsvarande en orga...
Ramlösa Shipping (”Ramlösa” eller ”Bolaget”) meddelade den 2 maj att Bolaget har ingått ett avtal om...
Redeye updates its forecast following Modelon’s Q1 2025 report, where results came roughly in line w...
Redeye initiates coverage of Indutrade, one of the largest Swedish niche acquirers, which has succes...
Trade policy shifts have led to softening cargo demand on a global basis, and hence we lower our fu...
Redeye comments on the preliminary Q1 figures, the cost-saving program, and the share issue.
Positive organic growth in Q1 and acceleration Q2-Q4e Estimates cut on divestments; underlying more ...
Last week, CI Games published its year-end report, which showed sales relatively in line with our es...
We open our Q&A on Medivir's Q1 report.
Kaktus divestment sold to Quantum Contributes SEK ~260m to EBIT in Q2’25 Divestment profit ~10% of m...
Redeye comments on OssDsign’s CEO change, announced earlier this week.
Redeye sees a couple of bright spots in the Q1 report, but the uncertain business climate still make...
Gapwaves posted a strong Q1, with net sales up 46% y/y and EBITDA excl.
Arise presented a quarter with many moving parts and one-off effects that blurred the underlying fin...
Redeye provides a comment following yesterday’s announcement from Catella regarding the divestment o...
Redeye strengthens its positive view of Formpipe following the Q1 report.
Redeye retains its positive stance towards Hexatronic following Q1.
Sales down 16% y-o-y as EEs remained flat q-o-q, 7% below us We push forward recovery a bit, but wil...
Minor estimate changes Record-level client intake & variable intake growth EV/ARR 2x, '25e EV/EBITDA...
